Bank Of Montreal Cybin Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$0.3 - $0.56 $900 - $1,680	3,000 Added 8.38%	38,800 $14,000
Q3 2022 Nov 10, 2022	SELL	$0.48 - $1.11 $714 - $1,651	-1,488 Reduced 3.99%	35,800 $18,000
Q2 2022 Aug 11, 2022	SELL	$0.41 - $0.88 $129 - $277	-315 Reduced 0.84%	37,288 $22,000
Q1 2022 May 12, 2022	BUY	$0.74 - $1.22 $1,334 - $2,199	1,803 Added 5.04%	37,603 $30,000
Q4 2021 Feb 11, 2022	SELL	$1.13 - $2.31 $8,194 - $16,752	-7,252 Reduced 16.84%	35,800 $44,000
Q3 2021 Nov 12, 2021	BUY	$1.83 - $3.18 $78,785 - $136,905	43,052 New	43,052 $102,000

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.58B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.